This chart shows the pharmaceutical companies with the most patents in Austria. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical companies have the most drug pate…
Which pharmaceutical companies have the most drug patents in Austria? Read Post »
Annual Drug Patent Expirations for STEGLUJAN Steglujan is a drug marketed by Merck Sharp Dohme and is included in one NDA. It is available from one supplier. There are five…
The post New patent for Merck Sharp drug STEGLUJAN appeared first on DrugPaten…
[](//www.DrugPatentWatch.com/p/preview/generic-api/ticagrelor?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog) Ticagrelor is the generic in…
New tentative approval for Dr Reddys drug ticagrelor Read Post »
Tirofiban hydrochloride is the generic ingredient in one branded drug marketed by Medicure and is included in two NDAs. There is one patent protecting this compound. Drug patent litigation for…
The post New tentative approval for Gland Pharma drug tiro…
New tentative approval for Gland Pharma drug tirofiban hydrochloride Read Post »
Annual Drug Patent Expirations for NEOPROFEN Neoprofen is a drug marketed by Recordati Rare and is included in one NDA. It is available from two suppliers. There are three patents…
The post New patent expiration for Recordati Rare drug NEOPROFEN appear…
New patent expiration for Recordati Rare drug NEOPROFEN Read Post »
This chart shows the pharmaceutical companies with the most suppository dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most suppository dosed drugs…
The post Which pharmaceutical companies have the m…
Which pharmaceutical companies have the most suppository dosed drugs? Read Post »
Annual Drug Patent Expirations for EPANED Epaned is a drug marketed by Azurity and Silvergate Pharms and is included in two NDAs. It is available from one supplier. There are…
The post New patent for Azurity drug EPANED appeared first on DrugPatentWatc…
Annual Drug Patent Expirations for ARISTADA Aristada is a drug marketed by Alkermes Inc and is included in two NDAs. It is available from one supplier. There are eleven patents…
The post New patent for Alkermes Inc drug ARISTADA appeared first on DrugP…
Annual Drug Patent Expirations for BRIVIACT Briviact is a drug marketed by Ucb Inc and is included in three NDAs. It is available from one supplier. There are four patents…
The post New patent for Ucb Inc drug BRIVIACT appeared first on DrugPatentWatch…
Annual Drug Patent Expirations for RADICAVA Radicava is a drug marketed by Mitsubishi Tanabe and is included in one NDA. It is available from one supplier. There is one patent…
The post New patent expiration for Mitsubishi Tanabe drug RADICAVA appeared…
New patent expiration for Mitsubishi Tanabe drug RADICAVA Read Post »
Get new actionable insights and updates from BiotechBlog
